SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001683168-24-000287 from BIOREGENX, INC. (BRGX) (CIK 0001593184) (BRGX)

BIOREGENX, INC. (BRGX) (CIK 0001593184)
Date: Jan. 16, 2024 · CIK: 0001593184 · Accession: 0001683168-24-000287

AI Filing Summary & Sentiment

File numbers found in text: 000-56345

Referenced dates: January 11, 2024

Date
January 16, 2024
Author
/s/Thomas Powers
Form
CORRESP
Company
BIOREGENX, INC. (BRGX) (CIK 0001593184)

Letter

Securities and Exchange Commission Revised Information Statement on Schedule 14C Filed January 3, 2024 File No. 000-56345

Re: Findit, Inc.

Dear Sir or Madam:

Pursuant to your comment letter dated January 11, 2024, please note the following:

Revised Information Statement on Schedule 14C -amendment 1

Information About Findit

Management's Discussion and Analysis of Financial Condition, page 56

1. Please update the management's discussion and analysis of financial condition to include the fiscal year ended December 31, 2022. Refer to Item 14(c)(1) of Schedule 14A.

Management’s Discussion and analysis of financial condition has been updated to include the fiscal year ended December 31, 2022.

Information Incorporated by Reference, page 132

2. We note your response to prior comment 3. Please revise to remove this section as you appear to be ineligible to incorporate by reference pursuant to Item 14(e)(1) to Schedule 14A.

The section “Information Incorporated by Reference has been removed.

Sincerely,
Findit, Inc.

Show Raw Text
CORRESP
1
filename1.htm

FINDIT, INC.

5051 Peachtree Corners Circle, #200

Peachtree Corners, GA 30092

January 16, 2024

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

  Re:
  Findit, Inc.

  Revised Information Statement on Schedule 14C

                               Filed January 3, 2024

  File No. 000-56345

Dear Sir or Madam:

Pursuant to your comment letter dated January 11, 2024, please note
the following:

Revised Information Statement on Schedule 14C -amendment 1

Information About Findit

Management's Discussion and Analysis of Financial Condition, page 56

1.
Please update the management's discussion and analysis of financial condition to include the fiscal year ended December 31, 2022.
Refer to Item 14(c)(1) of Schedule 14A.

Management’s Discussion and analysis of financial condition
has been updated to include the fiscal year ended December 31, 2022.

Information Incorporated by Reference, page 132

2.
We note your response to prior comment 3. Please revise to remove
this section as you appear to be ineligible to incorporate by reference pursuant to Item 14(e)(1) to Schedule 14A.

The section “Information Incorporated by
Reference has been removed.

Sincerely,

Findit, Inc.

/s/Thomas Powers

By: Thomas Powers, CEO